|
|
|
|
 |
|
|
|
復必泰本月內提出兒童版批准疫苗申請
(2021/9/10)
【明報專訊】復必泰(BioNTech)正計劃向全球多國的藥品管理局提出申請,批准使用向5至11歲孩童使用的疫苗。
該款兒科用疫苗,會是現下提供給12歲至17歲青少年使用的低劑量版。
|
|
|
|
|
|
|
|
| A D V E R T I S E M E N T |
|
| |
| |
| |
|
|
| |
| A D V E R T I S E M E N T |
|
| |
| |
| |
|
|
|
| |
|
|
|
| [] [] [] [] [] [] |
|
|
|
| MING PAO DAILY NEWS |
| A wholly owned subsidary of Ming Pao Enterprise Corporation Ltd. |
|
|
1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1
Tel.: (416) 321-0088 Fax: (416) 321-9663 Advertising Hotline Tel: (416) 673-8250
|
|
|
|
